Fathi Elloumi

发表

SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures

P. Meltzer, K. Kohn, W. Reinhold, 2020, Cell reports.

SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung Cancer Cell Lines based on their genomic signatures

P. Meltzer, K. Kohn, W. Reinhold, 2020, bioRxiv.

Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer.

Deepak K. Singh, A. Schetter, C. Harris, 2017, Cell reports.

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

N. Traficante, K. Mazan-Mamczarz, J. Shetty, 2022, bioRxiv.

A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data

Tieliu Shi, Leming Shi, W. Tong, 2010, The Pharmacogenomics Journal.

RNA sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.

P. Meltzer, W. Reinhold, Y. Pommier, 2019, Cancer research.

Artificial intelligence platform, RADR®, aids in the discovery of DNA damaging agent for the ultra-rare cancer Atypical Teratoid Rhabdoid Tumors

W. Reinhold, Y. Pommier, S. Varma, 2022, Frontiers in Drug Discovery.

A comparison of machine learning algorithms for chemical toxicity classification using a simulated multi-scale data model

Zhen Li, R. Woodrow Setzer, Richard S. Judson, 2008, BMC Bioinformatics.

Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines

Ludovic C. Gillet, C. Sander, P. Bork, 2019, iScience.

Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples

Zhiyuan Hu, Joel S Parker, Melissa A Troester, 2011, BMC Medical Genomics.

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

Kevin C. Dorff, Aaron M. Smalter, Stephen C. Harris, 2010, Nature Biotechnology.

ACToR--Aggregated Computational Toxicology Resource.

Ann Richard, Tommy Cathey, Richard Judson, 2008, Toxicology and applied pharmacology.

Tissue Banking, Bioinformatics, and Electronic Medical Records: The Front-End Requirements for Personalized Medicine

Kip Nalley, Fathi Elloumi, F. Elloumi, 2013, Journal of oncology.

TREML4 Promotes Inflammatory Programs in Human and Murine Macrophages and Alters Atherosclerosis Lesion Composition in the Apolipoprotein E Deficient Mouse

A. Finn, F. Kolodgie, L. Biesecker, 2020, Frontiers in Immunology.

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications

Y. Pommier, F. Elloumi, K. Pacak, 2022, Cancers.

Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation

W. Reinhold, Y. Pommier, J. Minna, 2022, iScience.

CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics

Chris Sander, Augustin Luna, Mirit I. Aladjem, 2020, Nucleic Acids Res..

Candidate biomarker assessment for pharmacological response

G. Mills, W. Reinhold, Y. Pommier, 2020, Translational oncology.

Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development

Y. Pommier, N. Onishi, F. Elloumi, 2021, PloS one.

Using pathway modules as targets for assay development in xenobiotic screening.

Imran Shah, Thomas B Knudsen, Richard S Judson, 2012, Molecular bioSystems.

Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers

C. Perou, F. Elloumi, J. Harrell, 2010, Molecular Cancer Research.

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents

Y. Pommier, V. Rajapakse, F. Elloumi, 2021, Molecular Cancer Therapeutics.

CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines

C. Sander, K. Kohn, W. Reinhold, 2018, iScience.

Integrative analysis of pharmacogenomics in major cancer cell line databases using CellMinerCDB

C. Sander, K. Kohn, W. Reinhold, 2018, bioRxiv.

NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells.

M. Cam, F. Elloumi, Eric Batchelor, 2017, Cancer research.

Financial distress and corporate governance: an empirical analysis

Jean-Pierre Gueyie, Fathi Elloumi, F. Elloumi, 2001 .

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

Todd H. Stokes, Kevin C. Dorff, Aaron M. Smalter, 2010, Nature Biotechnology.

Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype

S. Thorgeirsson, M. Heikenwalder, V. Factor, 2016, Hepatology.

NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells.

M. Cam, Eric Batchelor, M. Kruhlak, 2017, Cancer research.

SEARCHPATTOOL: a new method for mining the most specific frequent patterns for binding sites with application to prokaryotic DNA sequences

Martha Nason, Fathi Elloumi, M. Nason, 2007, BMC Bioinformatics.

Effects of the institutional environment on public-private partnership (P3) projects: Evidence from Canada

F. Elloumi, Hussein A. Warsame, O. Okafor, 2017 .

CEO compensation, IOS and the role of corporate governance

F. Elloumi, Jean-Pierre Gueyié, Fathi Elloumi, 2001 .

Impact of technical efficiency and input-driven growth in the Indian food processing sector

Asheref Illiyan, Fathi Elloumi, Vasim Akram, 2023, Journal of Economic and Administrative Sciences.

Novel and highly potent ATR inhibitor M4344 kills cancer cells with replication stress, and 1 enhances the chemotherapeutic activity of widely used DNA damaging agents

Y. Pommier, V. Rajapakse, F. Elloumi, 2021 .